Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Cardiovascular Diabetology
Published in: Cardiovascular Diabetology 1/2014

Open Access 01-12-2014 | Original investigation

National trends in utilization and outcomes of coronary revascularization procedures among people with and without type 2 diabetes in Spain (2001–2011)

Authors: Ana Lopez-de-Andres, Rodrigo Jimenez-García, Valentin Hernandez-Barrera, Napoleon Perez-Farinos, Jose M de Miguel-Yanes, Manuel Mendez-Bailon, Isabel Jimenez-Trujillo, Angel Gil de Miguel, Carmen Gallardo Pino, Pilar Carrasco-Garrido

Published in: Cardiovascular Diabetology | Issue 1/2014

Login to get access

Abstract

Background

Diabetes is associated with a high risk of death due to coronary artery disease (CAD). People with diabetes suffering from CAD are frequently treated with revascularization procedures. We aim to compare trends in the use and outcomes of coronary revascularization procedures in diabetic and non-diabetic patients in Spain between 2001 and 2011.

Methods

We identified all patients who had undergone coronary revascularization procedures, percutaneous coronary interventions (PCI) and coronary artery bypass graft (CABG) surgeries, using national hospital discharge data. Discharges were grouped by diabetes status: type 2 diabetes and no diabetes. The incidence of discharges attributed to coronary revascularization procedures were calculated stratified by diabetes status. We calculated length of stay and in-hospital mortality (IHM). We apply joinpoint log-linear regression to identify the years in which changes in tendency occurred in the use of PCI and CABG in diabetic and non-diabetic patients. Multivariate analysis was adjusted by age, sex, year and comorbidity (Charlson comorbidity index).

Results

From 2001 to 2011, 434,108 PCIs and 79,986 CABGs were performed. According to the results of the joinpoint analysis, we found that sex and age-adjusted use of PCI increased by 31.4% per year from 2001 to 2003, by 15.9% per year from 2003 to 2006 and by 3.8% per year from 2006 to 2011 in patients with diabetes. IHM among patients with diabetes who underwent a PCI did not change significantly over the entire study period (OR 0.99; 95% CI 0.97-1.00).
Among patients with diabetes who underwent a CABG, the sex and age-adjusted CABG incidence rate increased by 10.4% per year from 2001 to 2003, and then decreased by 1.1% through 2011. Diabetic patients who underwent a CABG had a 0.67 (95% CI 0.63-0.71) times lower probability of dying during hospitalization than those without diabetes.

Conclusions

The annual percent change in PCI procedures increased in diabetic and non-diabetic patients. Higher comorbidity and the female gender are associated with a higher IHM in PCI procedures. In diabetic and non-diabetic patients, we found a decrease in the use of CABG procedures. IHM was higher in patients without diabetes than in those with diabetes.
Appendix
Available only for authorised users
Literature
1.
Nelson SE: Management of patients with type 2 diabetes. Endocrinol Nutr. 2002, 49: 113-126. 10.1016/S1575-0922(02)74441-0.CrossRef
2.
Andrés E, Cordero A, Magán P, Alegría E, León M, Luengo E, Botaya RM, García Ortiz L, Casasnovas JA:Long-term mortality and hospital readmission after acute myocardial infarction: an eight-year follow-up study. Rev Esp Cardiol. 2012, 65: 414-420. 10.1016/j.recesp.2011.09.009.CrossRefPubMed
3.
Booth GL, Kapral MK, Fung K, Tu JV: Recent trends in cardiovascular complications among men and women with and without diabetes. Diabetes Care. 2006, 29: 32-37. 10.2337/diacare.29.01.06.dc05-0776.CrossRefPubMed
4.
Kamalesh M, Subramanian U, Ariana A, Sawada S, Tierney W: Similar decline in post-myocardial infarction mortality among subjects with and without diabetes. Am J Med Sci. 2005, 329: 228-233. 10.1097/00000441-200505000-00003.CrossRefPubMed
5.
Norhammar A, Lindback J, Ryden L, Wallentin L, Stenestrand U: Improved but still high short- and long-term mortality rates after myocardial infarction in patients with diabetes mellitus: A time-trend report from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care Admission. Heart. 2007, 93: 1577-1583.PubMedCentralCrossRefPubMed
6.
Svensson AM, Dellborg M, Abrahamsson P, Karlsson T, Herlitz J, Duval SJ, Berger AK, Luepker RV: The influence of a history of diabetes on treatment and outcome in acute myocardial infarction, during two time periods and in two different countries. Int J Cardiol. 2007, 119: 319-325. 10.1016/j.ijcard.2006.07.156.CrossRefPubMed
7.
Thomas RJ, Palumbo PJ, Melton LJ, Roger VL, Ransom J, O'Brien PC, Leibson CL: Trends in the mortality burden associated with diabetes mellitus: A population-based study in Rochester, Minn, 1970–1994. Arch Intern Med. 2003, 163: 445-451. 10.1001/archinte.163.4.445.CrossRefPubMed
8.
Ryden L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, Cosentino F, Jonsson B, Laakso M, Malmberg K, Priori S, Ostergren J, Tuomilehto J, Thrainsdottir I, Vanhorebeek I, Stramba-Badiale M, Lindgren P, Qiao Q, Priori SG, Blanc JJ, Budaj A, Camm J, Dean V, Deckers J, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A: Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J. 2007, 28: 88-136.CrossRefPubMed
9.
Flaherty JD, Davidson CJ: Diabetes and coronary revascularization. JAMA. 2005, 293: 1501-1508. 10.1001/jama.293.12.1501.CrossRefPubMed
10.
Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T, Garg S, Huber K, James S, Knuuti J, Lopez-Sendon J, Marco J, Menicanti L, Ostojic M, Piepoli MF, Pirlet C, Pomar JL, Reifart N, Ribichini FL, Schalij MJ, Sergeant P, Serruys PW, Silber S, Sousa Uva M, Taggart D, Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS); European Association for Percutaneous Cardiovascular Interventions (EAPCI): Guidelines on myocardial revascularization. Eur Heart J. 2010, 31: 2501-2555.CrossRefPubMed
11.
Mercado N, Wjins W, Serruys PW, Sigwart U, Flather MD, Stables RH, O'Neill WW, Rodriguez A, Lemos PA, Hueb WA, Gersh BJ, Booth J, Boersma E: One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials. J Thorac Cardiovasc Surg. 2005, 130: 512-519. 10.1016/j.jtcvs.2004.12.049.CrossRefPubMed
12.
Kappetein AP, Head SJ, Morice MC, Banning AP, Serruys PW, Mohr FW, Dawkins KD, Mack MJ, SYNTAX Investigators: Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial. Eur J Cardiothorac Surg. 2013, 43: 1006-1013. 10.1093/ejcts/ezt017.CrossRefPubMed
13.
Farkouh ME, Domanski M, Sleeper LA, Siami FS, Dangas G, Mack M, Yang M, Cohen DJ, Rosenberg Y, Solomon SD, Desai AS, Gersh BJ, Magnuson EA, Lansky A, Boineau R, Weinberger J, Ramanathan K, Sousa JE, Rankin J, Bhargava B, Buse J, Hueb W, Smith CR, Muratov V, Bansilal S, King S, Bertrand M, Fuster V, FREEDOM Trial Investigators: Strategies for multivessel revascularization in patients with diabetes. N Engl J Med. 2012, 367: 2375-2384. 10.1056/NEJMoa1211585.CrossRefPubMed
14.
Vamos EP, Millett C, Parsons C, Aylin P, Majeed A, Bottle A: Nationwide study on trends in hospital admissions for major cardiovascular events and procedures among people with and without diabetes in England, 2004–2009. Diabetes Care. 2012, 35: 265-272. 10.2337/dc11-1682.PubMedCentralCrossRefPubMed
15.
16.
Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987, 40: 373-383. 10.1016/0021-9681(87)90171-8.CrossRefPubMed
17.
Thomsen RW, Nielsen JS, Ulrichsen SP, Pedersen L, Hansen AM, Nilsson T: The Danish Centre for Strategic Research in Type 2 Diabetes (DD2) study: Collection of baseline data from the first 580 patients. Clin Epidemiol. 2012, 4: 43-48.PubMedCentralCrossRefPubMed
18.
19.
Kim HJ, Fay MP, Feuer EJ, Midthune DN: Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000, 19: 335-351. 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z.CrossRefPubMed
20.
National Cancer Institute: Joinpoint Regression Program, Version 4.0.4;Statistical Methodology and Applications Branch, Surveillance Research Program. National Cancer Institute, May 2013
21.
Ouhoummane N, Abdous B, Louchini R, Rochette L, Poirier P: Trends in postacute myocardial infarction managmenent and mortality in patients with diabetes. A population-based study from 1995 to 2001. Can J Cardiol. 2010, 26: 523-531. 10.1016/S0828-282X(10)70465-7.PubMedCentralCrossRefPubMed
22.
Bottle A, Millet C, Khunti K, Majeed A: Trends in cardiovascular admissions and procedures for people with and without diabetes in England, 1996–2005. Diabetologia. 2009, 52: 74-80. 10.1007/s00125-008-1170-1.CrossRefPubMed
23.
Rana JS, Venkitachalam L, Selzer F, Mulukutla SR, Marroquin OC, Laskey WK, Holper EM, Srinivas VS, Kip KE, Kelsey SF, Nesto RW, NHLBI-sponsored PTCA and Dynamic Registries Investigators: Evolution of percutaneous coronary intervention in patients with diabetes. A report from the National Heart, Lung, and Blood Institute-sponsored PTCA (1985–1986) and Dynamic (1997–2006) Registries. Diabetes Care. 2010, 33: 1976-1982. 10.2337/dc10-0247.PubMedCentralCrossRefPubMed
24.
Verma S, Farkouh ME, Yanagawa B, Fitchett DH, Ahsan MR, Ruel M, Sud S, Gupta M, Singh S, Gupta N, Cheema AN, Leiter LA, Fedak PWM, Teoh H, Latte DA, Fuster V, Friedrich JO: Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes: a meta-analysis of randomised controlled trials. Lancet Diabetes Endocrinol. 2013, 1: 317-328. 10.1016/S2213-8587(13)70089-5.CrossRefPubMed
25.
Contini GA, Nicolini F, Fortuna D, Pacini D, Gabbieri D, Vignali L, Valgimigli M, Manari A, Zussa C, Guastaroba P, De Palma R, Grilli R, Gherli T: Five-year outcomes of surgical or percutaneous myocardial revascularization in diabetic patients. Int J Cardiol. 2013, 168: 1028-1033. 10.1016/j.ijcard.2012.10.030.CrossRefPubMed
26.
Mazurek M, Kowalczyk J, Lenarczyk R, Zielinska T, Sedkowska A, Pruszkowska-Skrzep P, Swiatkowski A, Sredniawa B, Kowalski O, Polonski L, Strojek K, Kalarus Z: The prognostic value of different glucose abnormalities in patients with acute myocardial infarction treated invasively. Cardiovasc Diabetol. 2012, 11: 78-10.1186/1475-2840-11-78.PubMedCentralCrossRefPubMed
27.
Kuramitsu S, Yokoi H, Domei T, Nomura A, Watanabe H, Yamaji K, Soga Y, Arita T, Kondo K, Shirai S, Ando K, Sakai K, Iwabuchi M, Nosaka H, Nobuyoshi M: Impact of post-challenge hyperglycemia on clinical outcomes in japanese patients with stable angina undergoing percutaneous coronary intervention. Cardiovasc Diabetol. 2013, 12: 74-10.1186/1475-2840-12-74.PubMedCentralCrossRefPubMed
28.
Kassaian SE, Goodarzynejad H, Boroumand MA, Salarifar M, Masoudkabir F, Mohajeri-Tehrani MR, Pourhoseini H, Sadeghian S, Ramezanpour N, Alidoosti M, Hakki E, Saadat S, Nematipour E: Glycosylated hemoglobin (HbA1c) levels and clinical outcomes in diabetic patients following coronary artery stenting. Cardiovasc Diabetol. 2012, 11: 82-10.1186/1475-2840-11-82.PubMedCentralCrossRefPubMed
29.
Holper EM, Abbott JD, Mulukutla S, Vlachos H, Selzer F, McGuire D, Faxon DP, Laskey W, Srinivas VS, Marroquin OC, Jacobs AK: Temporal changes in the outcomes of patients with diabetes mellitus undergoing percutaneous coronary intervention in the National Heart, Lung, and Blood Institute dynamic registry. Am Heart J. 2011, 161: 397-403. 10.1016/j.ahj.2010.11.004.CrossRefPubMed
30.
Hillegass WB, Patel MR, Klein LW, Gurm HS, Brennan JM, Anstrom KJ, Dai D, Eisenstein EL, Peterson ED, Messenger JC, Douglas PS: Long-Term Outcomes of Older Diabetic Patients After Percutaneous Coronary Stenting in the United States. J Am Coll Cardiol. 2012, 60: 2280-2289. 10.1016/j.jacc.2012.08.993.CrossRefPubMed
31.
Hassan A, Newman A, Ko DT, Rinfret S, Hirsch G, Ghali WA, Tu JV: Increasing rates of angioplasty versus bypass surgery in Canada, 1994–2005. Am Heart J. 2010, 160: 958-965. 10.1016/j.ahj.2010.06.052.CrossRefPubMed
32.
Elbarouni B, Ismaeil N, Yan RT, Fox KA, Connelly KA, Baer C, DeYoung JP, Gallo R, Ramanathan K, Pesant Y, Leiter LA, Goodman SG, Yan AT: Temporal changes in the management and outcome of Canadian diabetic patients hospitalized for non–ST-elevation acute coronary syndromes. Am Heart J. 2011, 162: 347-355. 10.1016/j.ahj.2011.05.020.CrossRefPubMed
33.
Kang JS, Goodman SG, Yan RT, Lopez-Sendon J, Pesant Y, Graham JJ, Fitchett D, Wong GC, Rose BF, Spencer FA, Yan AT, Canadian GRACE and CANRACE Investigators: Management and Outcomes of Non-ST Elevation Acute Coronary Syndromes in Relation to Previous Use of Antianginal Therapies (from the Canadian Global Registry of Acute Coronary Events [GRACE] and Canadian Registry of Acute Coronary Events [CANRACE]). Am J Cardiol. 2013, 112: 51-56. 10.1016/j.amjcard.2013.02.053.CrossRefPubMed
34.
García-Armesto S, Abadía-Taira MB, Durán A, Hernández-Quevedo C, Bernal-Delgado E: Spain: Health system review. Health Syst Transit. 2010, 12: 1-295.PubMed
35.
Boyle S: United Kingdom (England): Health system review. Health Syst Transit. 2011, 13: 1-486.PubMed
36.
Maier B, Thimme W, Kallischnigg G, Graf-Bothe C, Rohnisch JU, Hegenbarth C, Theres H, Berlin Myocardial Infarction Registry: Does diabetes mellitus explain the higher hospital mortality of women with acute myocardial infarction? Results from the Berlin Myocardial Infarction Registry. J Investig Med. 2006, 54: 143-151.CrossRefPubMed
37.
Champney KP, Veledar E, Klein M, Samady H, Anderson D, Parashar S, Wenger N, Vaccarino V: Sex-specific effects of diabetes on adverse outcomes after percutaneous coronary intervention: trends over time. Am Heart J. 2007, 153: 970-978. 10.1016/j.ahj.2007.03.036.CrossRefPubMed
38.
Blöndal M, Ainla T, Marandi T, Baburin A, Eha J: Sex-specific outcomes of diabetic patients with acute myocardial infarction who have undergone percutaneous coronary intervention: a register linkage study. Cardiovasc Diabetol. 2012, 11: 96-10.1186/1475-2840-11-96.PubMedCentralCrossRefPubMed
39.
López-de-Andrés A, Martínez-Huedo MA, Carrasco-Garrido P, Hernández-Barrera V, Gil-de-Miguel A, Jimenez-Garcia R: Trends in lower-extremity amputations in people with and without diabetes in Spain, 2001–2008. Diabetes Care. 2011, 34: 1570-1576. 10.2337/dc11-0077.PubMedCentralCrossRefPubMed
40.
López de Andrés A, Jiménez-García R, Hernández-Barrera V, Gil-de-Miguel A, Jiménez-Trujillo MI, Carrasco-Garrido P: Trends in utilization and outcomes of bariatric surgery in obese people with and without type 2 diabetes in Spain (2001–2010). Diabetes Res Clin Pract. 2013, 99: 300-306. 10.1016/j.diabres.2012.12.011.CrossRefPubMed
41.
Ruiz-Ramos M, Escolar-Pujolar A, Mayoral-Sánchez E, Corral-San Laureano F, Fernández-Fernández I: Diabetes mellitus in Spain: death rates, prevalence, impact, costs and inequalities. Gac Sanit. 2006, 20: 15-24.CrossRefPubMed
42.
Ferreira-González I, Cascant P, Pons JM, Mitjavila F, Salas T, Permanyer-Miralda G: Predicting in-hospital mortality with coronary bypass surgery using hospital discharge data: comparison with a prospective observational study. Rev Esp Cardiol. 2008, 61: 843-852. 10.1157/13124995.CrossRefPubMed
Metadata
Title
National trends in utilization and outcomes of coronary revascularization procedures among people with and without type 2 diabetes in Spain (2001–2011)
Authors
Ana Lopez-de-Andres
Rodrigo Jimenez-García
Valentin Hernandez-Barrera
Napoleon Perez-Farinos
Jose M de Miguel-Yanes
Manuel Mendez-Bailon
Isabel Jimenez-Trujillo
Angel Gil de Miguel
Carmen Gallardo Pino
Pilar Carrasco-Garrido
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2014
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/1475-2840-13-3

Other articles of this Issue 1/2014

Cardiovascular Diabetology 1/2014 Go to the issue

Original investigation

Bezafibrate improves postprandial hypertriglyceridemia and associated endothelial dysfunction in patients with metabolic syndrome: a randomized crossover study

Original investigation

Association of impaired fasting glucose, diabetes and their management with the presentation and outcome of peripheral artery disease: a cohort study

Original investigation

Myocardial blood flow under general anaesthesia with sevoflurane in type 2 diabetic patients: a pilot study

Original investigation

Azilsartan, an angiotensin II type 1 receptor blocker, restores endothelial function by reducing vascular inflammation and by increasing the phosphorylation ratio Ser1177/Thr497 of endothelial nitric oxide synthase in diabetic mice

Original investigation

Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance

Original investigation

Flow-mediated-paradoxical vasoconstriction is independently associated with asymptomatic myocardial ischemia and coronary artery disease in type 2 diabetic patients
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits